FDA commish contenders under final review at White House; Inside Eli Lilly’s massive dealmaking spree; Idaho mother charged ...

Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...

Spectrum Science, a 2026 MM+M Agency 100 honoree, is elevating chief commercial officer Marie Emms to president of its ...

HCPs and patients don’t behave the way you buy. They are not disconnected groups. The leaders on this IQVIA Digital-hosted ...

The modern healthcare landscape is in an era where clinical innovation alone no longer guarantees market success. Instead, ...

Patients seek solutions and trust, two elements that can be elusive. The leaders on this panel at Cannes highlighted how ...

The FDA's Office of Prescription Drug Promotion issued an untitled letter to Lundbeck over claims on its webpages for the ...

The Hikma v. Amarin ruling brings clarity, but not new opportunities; White House adds pandemic response staff as Ebola cases ...

The obesity rate falls as GLP-1s rise; DTC telehealth companies are prescribing GLP-1s at alarming rates; FDA approvals of ...

Next year, Medicaid recipients will have to start showing documentation such as a doctor’s note to avoid a new work ...

The 2026 MM+M Agency 100 honoree says Martis Capital's investment will fuel AI innovation, talent development and strategic ...

RFK Jr. wants you to get more preventive care. Some experts say that's a bad idea; AI is expected to automate healthcare ...